In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

If you are mass torts lawyer, you should be paying attention to a trend that has emerged in litigation over the discontinued heartburn medication Zantac.

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product. In a unanimous ruling Thursday, the ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a major win for makers of the product. In a unanimous ruling Thursday, the ...

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may ...

Most of the Delaware lawsuits claim Zantac caused types of cancer, including prostate, breast and colorectal cancer, that plaintiffs' lawyers dropped from the federal litigation in order to focus ...

The Delaware Supreme Court should uphold its state's reputation and reverse a lower court's acceptance of poor scientific evidence in a mass tort case.

On the Toxic Tort Docket Note: These are intermediate findings, and final decisions are yet to come. For the moment, things bode well for the defense. “Meso” [sic] is not a Japanese Soup Read more ...

GSK shares higher after Delaware Zantac rulingShould you invest $2,000 in SASY right now? With SASY making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of ...